FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136287018> ?p ?o ?g. }

• W3136287018 endingPage "1594" @default.
• W3136287018 startingPage "1594" @default.
• W3136287018 abstract "A series of novel functionalized methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates 2a–2h were synthesized by C-C Pd-catalyzed Suzuki-Miyaura cross-coupling of methyl 3-bromothieno[3,2-b]pyridine-2-carboxylate with (hetero)aryl pinacol boranes, trifluoro potassium boronate salts or boronic acids. Their antitumoral potential was evaluated in two triple negative breast cancer (TNBC) cell lines—MDA-MB-231 and MDA-MB-468, by sulforhodamine B assay. Their effects on the non-tumorigenic MCF-12A cells were also evaluated. The results demonstrated that three compounds caused growth inhibition in both TNBC cell lines, with little or no effect against the non-tumorigenic cells. The most promising compound was further studied concerning possible effects on cell viability (by trypan blue exclusion assay), cell proliferation (by bromodeoxyuridine assay) and cell cycle profile (by flow cytometry). The results demonstrated that the GI50 concentration of compound 2e (13 μM) caused a decreased in MDA-MB-231 cell number, which was correlated with a decreased in the % of proliferating cells. Moreover, this compound increased G0/G1 phase and decreased S phases, when compared to control cells (although was not statistic significant). Interestingly, compound 2e also reduced tumor size using an in ovo CAM (chick chorioallantoic membrane) model. This work highlights the potential antitumor effect of a novel methyl 3-arylthieno[3,2-b]pyridine-2-carboxylate derivative." @default.
• W3136287018 created "2021-03-29" @default.
• W3136287018 creator A5029657252 @default.
• W3136287018 creator A5035724791 @default.
• W3136287018 creator A5040669857 @default.
• W3136287018 creator A5047567407 @default.
• W3136287018 creator A5051304797 @default.
• W3136287018 creator A5064793459 @default.
• W3136287018 date "2021-03-13" @default.
• W3136287018 modified "2023-10-16" @default.
• W3136287018 title "Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and Antitumor Activity Evaluation: Studies In Vitro and In Ovo Grafts of Chick Chorioallantoic Membrane (CAM) with a Triple Negative Breast Cancer Cell Line" @default.
• W3136287018 cites W1416958482 @default.
• W3136287018 cites W1975223905 @default.
• W3136287018 cites W1983790923 @default.
• W3136287018 cites W1985801265 @default.
• W3136287018 cites W1986526274 @default.
• W3136287018 cites W2013824261 @default.
• W3136287018 cites W2018072961 @default.
• W3136287018 cites W2027542963 @default.
• W3136287018 cites W2047335308 @default.
• W3136287018 cites W2073001877 @default.
• W3136287018 cites W2073891761 @default.
• W3136287018 cites W2106292881 @default.
• W3136287018 cites W2145577158 @default.
• W3136287018 cites W2159643059 @default.
• W3136287018 cites W2173949843 @default.
• W3136287018 cites W2176592108 @default.
• W3136287018 cites W2241240909 @default.
• W3136287018 cites W2350982714 @default.
• W3136287018 cites W2402636472 @default.
• W3136287018 cites W2503467523 @default.
• W3136287018 cites W2602911552 @default.
• W3136287018 cites W2762285338 @default.
• W3136287018 cites W2774248760 @default.
• W3136287018 cites W2887014156 @default.
• W3136287018 cites W2887431520 @default.
• W3136287018 cites W2911538979 @default.
• W3136287018 cites W2914498996 @default.
• W3136287018 cites W2948043287 @default.
• W3136287018 cites W2952115946 @default.
• W3136287018 cites W3026311750 @default.
• W3136287018 cites W4237461109 @default.
• W3136287018 doi "https://doi.org/10.3390/molecules26061594" @default.
• W3136287018 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7999514" @default.
• W3136287018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33805741" @default.
• W3136287018 hasPublicationYear "2021" @default.
• W3136287018 type Work @default.
• W3136287018 sameAs 3136287018 @default.
• W3136287018 citedByCount "2" @default.
• W3136287018 countsByYear W31362870182022 @default.
• W3136287018 crossrefType "journal-article" @default.
• W3136287018 hasAuthorship W3136287018A5029657252 @default.
• W3136287018 hasAuthorship W3136287018A5035724791 @default.
• W3136287018 hasAuthorship W3136287018A5040669857 @default.
• W3136287018 hasAuthorship W3136287018A5047567407 @default.
• W3136287018 hasAuthorship W3136287018A5051304797 @default.
• W3136287018 hasAuthorship W3136287018A5064793459 @default.
• W3136287018 hasBestOaLocation W31362870181 @default.
• W3136287018 hasConcept C109316439 @default.
• W3136287018 hasConcept C153911025 @default.
• W3136287018 hasConcept C185592680 @default.
• W3136287018 hasConcept C196843134 @default.
• W3136287018 hasConcept C202751555 @default.
• W3136287018 hasConcept C2776074239 @default.
• W3136287018 hasConcept C2778765379 @default.
• W3136287018 hasConcept C2780070996 @default.
• W3136287018 hasConcept C53227056 @default.
• W3136287018 hasConcept C54355233 @default.
• W3136287018 hasConcept C553184892 @default.
• W3136287018 hasConcept C55493867 @default.
• W3136287018 hasConcept C62112901 @default.
• W3136287018 hasConcept C71240020 @default.
• W3136287018 hasConcept C81885089 @default.
• W3136287018 hasConcept C86803240 @default.
• W3136287018 hasConcept C95444343 @default.
• W3136287018 hasConcept C97230052 @default.
• W3136287018 hasConceptScore W3136287018C109316439 @default.
• W3136287018 hasConceptScore W3136287018C153911025 @default.
• W3136287018 hasConceptScore W3136287018C185592680 @default.
• W3136287018 hasConceptScore W3136287018C196843134 @default.
• W3136287018 hasConceptScore W3136287018C202751555 @default.
• W3136287018 hasConceptScore W3136287018C2776074239 @default.
• W3136287018 hasConceptScore W3136287018C2778765379 @default.
• W3136287018 hasConceptScore W3136287018C2780070996 @default.
• W3136287018 hasConceptScore W3136287018C53227056 @default.
• W3136287018 hasConceptScore W3136287018C54355233 @default.
• W3136287018 hasConceptScore W3136287018C553184892 @default.
• W3136287018 hasConceptScore W3136287018C55493867 @default.
• W3136287018 hasConceptScore W3136287018C62112901 @default.
• W3136287018 hasConceptScore W3136287018C71240020 @default.
• W3136287018 hasConceptScore W3136287018C81885089 @default.
• W3136287018 hasConceptScore W3136287018C86803240 @default.
• W3136287018 hasConceptScore W3136287018C95444343 @default.
• W3136287018 hasConceptScore W3136287018C97230052 @default.
• W3136287018 hasFunder F4320334779 @default.
• W3136287018 hasFunder F4320335322 @default.
• W3136287018 hasFunder F4320338080 @default.
• W3136287018 hasIssue "6" @default.

• next